F7Y logo

Gaush Meditech DB:F7Y Stock Report

Last Price

€1.22

Market Cap

€183.7m

7D

0%

1Y

-69.3%

Updated

22 Dec, 2024

Data

Company Financials

F7Y Stock Overview

Engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. More details

F7Y fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health5/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Gaush Meditech Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Gaush Meditech
Historical stock prices
Current Share PriceHK$1.22
52 Week HighHK$4.20
52 Week LowHK$1.01
Beta-0.41
1 Month Change3.39%
3 Month Change18.45%
1 Year Change-69.35%
3 Year Changen/a
5 Year Changen/a
Change since IPO-75.46%

Recent News & Updates

Recent updates

Shareholder Returns

F7YDE Medical EquipmentDE Market
7D0%-2.9%-2.6%
1Y-69.3%-8.5%6.9%

Return vs Industry: F7Y underperformed the German Medical Equipment industry which returned -8.5% over the past year.

Return vs Market: F7Y underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is F7Y's price volatile compared to industry and market?
F7Y volatility
F7Y Average Weekly Movement12.2%
Medical Equipment Industry Average Movement6.6%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: F7Y's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: F7Y's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1998872Xinwei Liuwww.gaush.com

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprises of proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd.

Gaush Meditech Ltd Fundamentals Summary

How do Gaush Meditech's earnings and revenue compare to its market cap?
F7Y fundamental statistics
Market cap€183.74m
Earnings (TTM)€11.91m
Revenue (TTM)€177.01m

15.4x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
F7Y income statement (TTM)
RevenueCN¥1.35b
Cost of RevenueCN¥720.22m
Gross ProfitCN¥627.35m
Other ExpensesCN¥536.65m
EarningsCN¥90.70m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.61
Gross Margin46.55%
Net Profit Margin6.73%
Debt/Equity Ratio36.5%

How did F7Y perform over the long term?

See historical performance and comparison

Dividends

10.5%

Current Dividend Yield

163%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:02
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Gaush Meditech Ltd is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Youjue HuMorgan Stanley